A Third Amlodipine/ARB Combination (Twynsta) for Hypertension
The FDA has approved Twynsta (Boehringer Ingelheim), a fixed-dose combination of the calcium-channel blocker (CCB) amlodipine and the angiotensin receptor blocker (ARB) telmisartan, for treatment of hypertension....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: A Third Amlodipine/ARB Combination (Twynsta) for Hypertension
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1329
Article Code: 1329b
Date: January 11, 2010
Volume: 52
Pages: 2-3
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1329
Article Code: 1329b
Date: January 11, 2010
Volume: 52
Pages: 2-3
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)